80 related articles for article (PubMed ID: 1759430)
1. [HLA antigens in patients with different forms of arterial hypertension].
Titkov IuS; Ziskina RA; Temirov AA; Dzhibladze DV
Vrach Delo; 1991 Sep; (9):46-7. PubMed ID: 1759430
[TBL] [Abstract][Full Text] [Related]
2. [The characteristics of HLA antigen distribution in patients with chronic glomerulonephritis and arterial hypertension].
Karazhanov LK
Urol Nefrol (Mosk); 1994; (3):33-4. PubMed ID: 8079409
[TBL] [Abstract][Full Text] [Related]
3. HLA antigens in borderline and essential hypertension.
Titkov YS; Ziskina RA; Temirov AA; Gybladze DV; Bubnova LN
Am J Hypertens; 1993 Oct; 6(10):885-7. PubMed ID: 8267946
[TBL] [Abstract][Full Text] [Related]
4. [Immunogenetic blood markers as a risk factor of development of periodic disease in Armenian population].
Nersisian VM; Astvatsatrian VA; Zakharian AG; Musaelian NO; Martirosian IG
Ter Arkh; 2006; 78(4):76-8. PubMed ID: 16821429
[TBL] [Abstract][Full Text] [Related]
5. [Various immunological aspects of essential and symptomatic hypertension].
Shkhvatsabaia IK; Rudnev VI; Suvorov IuI; Domba GIu; Osipov SG
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1988; 11(1):7-12. PubMed ID: 3165269
[TBL] [Abstract][Full Text] [Related]
6. [The immunogenetic heterogeneity of chronic glomerulonephritis].
Karazhanova LK
Ter Arkh; 1995; 67(8):5-7. PubMed ID: 7482336
[TBL] [Abstract][Full Text] [Related]
7. HLA antigens and the complement system in essential hypertension.
Shkhvatsabaya IK; Osipov SG; Suvorov YuI ; Rudnev VI; Titov VN
Cor Vasa; 1984; 26(6):408-14. PubMed ID: 6525875
[TBL] [Abstract][Full Text] [Related]
8. [The role of immunogenetic research in studying hypertension].
Tkachenko EV; Baĭ EN
Vrach Delo; 1989 Oct; (10):75-6. PubMed ID: 2617992
[TBL] [Abstract][Full Text] [Related]
9. Human leukocyte antigen frequency in human high-grade gliomas: a case-control study in Sicily.
La Torre D; Maugeri R; Angileri FF; Pezzino G; Conti A; Cardali SM; Calisto A; Sciarrone G; Misefari A; Germanò A; Tomasello F
Neurosurgery; 2009 Jun; 64(6):1082-8; discussion 1088-9. PubMed ID: 19487887
[TBL] [Abstract][Full Text] [Related]
10. HLA phenotypes as promoters of cardiovascular remodelling in subjects with arterial hypertension.
Diamantopoulos EJ; Andreadis EA; Vassilopoulos CV; Vlachonikolis IG; Tarassi KE; Chatzis NA; Tsourous GI; Papasteriades CA
J Hum Hypertens; 2003 Jan; 17(1):63-8. PubMed ID: 12571618
[TBL] [Abstract][Full Text] [Related]
11. [The characteristics of HLA antigen distribution among patients with persistent lambliasis].
Osipova SO; Niiazova OP; Shimolin AP; Dekhkan-Khodzhaeva NA
Med Parazitol (Mosk); 1994; (2):11-3. PubMed ID: 7935180
[TBL] [Abstract][Full Text] [Related]
12. [The factors of hereditary predisposition to lymphogranulomatosis].
Zaretskaia IuM; Pivnik AV; Klinova EG; Rasstrigin NA; Khamaganova EG; Aleshchenko SM; Margolin OV
Ter Arkh; 1998; 70(7):53-7. PubMed ID: 9742638
[TBL] [Abstract][Full Text] [Related]
13. [HLA antigens in persons with a predisposition to frequent sympathetic-adrenal paroxysms].
Ismagilov MF; Tananov AT; Kurmyshkin AA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(5-12):35-7. PubMed ID: 1338153
[TBL] [Abstract][Full Text] [Related]
14. An immunogenetic study in hypertrophic cardiomyopathy.
Gregor P; Ivasková E; Sajdlová H; Kupková L; Widimský P; Cervenka V
Cor Vasa; 1991; 33(5):414-23. PubMed ID: 1810702
[TBL] [Abstract][Full Text] [Related]
15. [Relationship between HLA antigens and the HIV infection in patients from the state of Zulia].
Hassanhi MS; Rivera SE; Fuenmayor AM; Márquez GC; Salas D; de Avila LM; Sanabria A; de Ruiz Z
Sangre (Barc); 1995 Apr; 40(2):109-13. PubMed ID: 7784939
[TBL] [Abstract][Full Text] [Related]
16. Serological and molecular studies of HLA in Sardinian patients with Graves' disease.
La Nasa G; Martino E; Carcassi C; Mulargia M; Floris L; Vacca A; Baldini G; Orrù S; Ledda A; Grasso L
Dis Markers; 1991; 9(6):307-12. PubMed ID: 1823309
[TBL] [Abstract][Full Text] [Related]
17. HLA antigens and anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease.
García Herola A; Nos P; Hinijosa J; Hoyos M; Molés JR; Carmona E; Puig N; Sánchez-Cuenca JM; Ponce J; Berenguer J
Rev Esp Enferm Dig; 2003 Nov; 95(11):760-4, 755-9. PubMed ID: 14640873
[TBL] [Abstract][Full Text] [Related]
18. [HLA antigens in patients with rheumatoid arthritis, their relatives, and spouses].
Mataran Pérez L; Rodríguez Pérez M; González Domínguez J; Gutiérrez Gea F; Abellán Pérez M; Salvatierra Ríos D
An Med Interna; 1990 Mar; 7(3):129-32. PubMed ID: 2103766
[TBL] [Abstract][Full Text] [Related]
19. [The immunogenetic risk factors in the nephrotic syndrome].
Shishkin AN; Ashirova KV; Balliuzek MF; Volovnikova VA
Ter Arkh; 1994; 66(6):32-4. PubMed ID: 7940362
[TBL] [Abstract][Full Text] [Related]
20. [HL-A system antigen distribution in malignant neoplasm patients].
Dzhaginian AI; Serova LD; Shabalin VN; Balliuzek FV
Vopr Onkol; 1977; 23(10):53-9. PubMed ID: 145736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
